Newsfeed : New Female Condom Awaits FDA Approval

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » December 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

December 11, 2008

New Female Condom Awaits FDA Approval

This week, a U.S. Food and Drug Administration (FDA) advisory panel will to decide whether a new female condom can adequately prevent pregnancy, HIV and other sexually transmitted infections, Reuters reports.

While previous female condoms were made from polyurethane, this new condom, the FC2 Female Condom, is made with a synthetic rubber called nitrile through a process similar to that of male condoms, which the manufacturer says will reduce its current cost. According to the article, current female condoms cost between $2.80 and $4 each compared with male condoms, which cost about 50 cents each and are more widely used.

The FC2 manufacturer, Female Health Co., says that that FDA approval could help boost sales of female condoms in the United States, which made up just 10 percent of the female condom’s 34.7 million unit sales worldwide in 2008. The female condoms are mostly used in Africa, where public health agencies distribute them.

“We haven’t been able to market the product,” said Mary Ann Leeper, an adviser and former president of Female Health Co. She added that the company seeks to partner with a male condom manufacturer or drugmaker invested in HIV awareness.

Search: FDA, female condom, Female Health Co, nitrile


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    Hillcrester
    Ramona
    California


    Poz_Qt
    Columbus
    Ohio


    hollywoodvers1
    Los Angeles
    California


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.